Clinical Trials List
Protocol NumberHuL001-CT-102
2024-12-02 - 2027-12-31
Phase I/II
Recruiting1
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
21 participants
